Ensysce Biosciences, Inc. · NASDAQ:ENSC
Ensysce Biosciences, Inc. shareholders
As of Jun 30, 2026, 18 institutions reported holding Ensysce Biosciences, Inc., 4.7% of its shares. Largest: Jane Street, Adage Capital Partners Gp, L.L.C. and Virtu Financial LLC. New holders, exits, insiders and big stakes, each with its filing.
| Holder | Shares | % of Ensysce Biosciences, Inc. | Change | Filed |
|---|---|---|---|---|
| Jane Street | 209K | 1.1% | +195K | Aug 14, 2026 |
| Adage Capital Partners Gp, L.L.C. | 150K | 0.77% | no change | Aug 14, 2026 |
| Virtu Financial LLC | 95,391 | 0.49% | +82,078 | Aug 13, 2026 |
| Perceptive Advisors LLC | 86,666 | 0.45% | no change | Aug 14, 2026 |
| Citadel | 86,193 | 0.44% | +28,830 | Aug 14, 2026 |
| XTX Topco Ltd | 77,005 | 0.40% | +52,642 | Aug 14, 2026 |
| Geode Capital | 62,188 | 0.32% | −11,692 | Aug 12, 2026 |
| Hrt Financial LP | 54,429 | 0.28% | new | Aug 14, 2026 |
| Susquehanna | 34,280 | 0.18% | new | Aug 14, 2026 |
| Tru Independence Asset Management 2, LLC | 13,000 | 0.07% | no change | Aug 11, 2026 |